Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway

Pharmaceutical Particle Engineering via Spray Drying

Vehring, R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9475-1 · Cited by 1,698 · see citing works

The emerging role of the Nrf2–Keap1 signaling pathway in cancerPreprint

Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,304 · see citing works

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

Tuder, R. M., Groves, B. Μ., Badesch, D. B., & Voelkel, N. F. (1994) · PubMed Central · Cited by 790 · see citing works

Nanomedicine in pulmonary delivery

Mansour, H. M., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 486 · see citing works

Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation

Wilms, H., Sievers, J., Rickert, U., Rostami‐Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 346 · see citing works

Targeting Nrf2 Signaling Improves Bacterial Clearance by Alveolar Macrophages in Patients with COPD and in a Mouse Model

Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L. B., Brown, R. H., Feller-Kopman, D. J., Wise, R. A., & Biswal, S. S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002042 · Cited by 343 · see citing works

Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells

Chen, X.-L., Varner, S. E., Rao, A. S., Grey, J. Y., Thomas, S., Cook, C. K., Wasserman, M. A., Medford, R. M., Jaiswal, A. K., & Kunsch, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203161200 · Cited by 333 · see citing works

Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview

Bomprezzi, R. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285614564152 · Cited by 301 · see citing works

PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria

Lo, S.-C., & Hannink, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.014 · Cited by 300 · see citing works

Inhalable nanoparticulate powders for respiratory delivery

Muralidharan, P., Malapit, M., Mallory, E. K., Hayes, D., & Mansour, H. M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.01.007 · Cited by 233 · see citing works

Differential Responses of the Nrf2-Keap1 System to Laminar and Oscillatory Shear Stresses in Endothelial Cells

Hosoya, T., Maruyama, A., Kang, M.-I., Kawatani, Y., Shibata, T., Uchida, K., Itoh, K., & Yamamoto, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502551200 · Cited by 227 · see citing works

Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents

Feng, J., Liu, X., Li, L., Mallapragada, S. K., Narasimhan, B., & Wang, Q. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.012 · Cited by 222 · see citing works

Impaired Redox Signaling and Antioxidant Gene Expression in Endothelial Cells in Diabetes: A Role for Mitochondria and the Nuclear Factor-E2-Related Factor 2-Kelch-Like ECH-Associated Protein 1 Defense Pathway

Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 178 · see citing works

Nanotechnology-based inhalation treatments for lung cancer: state of the art

Akhter, S., Ahmad, J., Rizwanullah, M., Rahman, M., Ahmad, M. Z., Rizvi, M. M. A., Ahmad, F. J., Amin, S., & Kamal, M. A. (2015) · Nanotechnology Science and Applications · doi:10.2147/nsa.s49052 · Cited by 175 · see citing works

In Utero Placement of Aortopulmonary Shunts

Reddy, V. M., Meyrick, B. O., Wong, J. Y., Khoór, A., Liddicoat, J. R., Hanley, F. L., & Fineman, J. R. (1995) · Circulation · doi:10.1161/01.cir.92.3.606 · Cited by 161 · see citing works

Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148 · see citing works

Asthma and COPD : Basic Mechanisms and Clinical Management

Barnes, P. J. (2002) · Cited by 145 · see citing works

Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia

Fresquet, F., Pourageaud, F., Leblais, V., Brandes, R. P., Savineau, J., Marthan, R., & Müller, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706779 · Cited by 142 · see citing works

Drug Properties Affecting Aerosol Behavior

Suarez, S., & Hickey, A. J. (2000) · Respiratory Care · doi:10.1177/002013240004500609 · Cited by 128 · see citing works

Airway inflammation in chronic obstructive pulmonary disease.

Angelis, N., Porpodis, Κ., Zarogoulidis, P., Spyratos, D., Kioumis, I. P., Papaiwannou, A., Pitsiou, G., Tsakiridis, K., Mpakas, A., Arikas, S., et al. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2014.03.07 · Cited by 123 · see citing works

Conditional Deletion of Nrf2 in Airway Epithelium Exacerbates Acute Lung Injury and Impairs the Resolution of Inflammation

Reddy, N. M., Potteti, H. R., Mariani, T. J., Biswal, S. S., & Reddy, S. P. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0144oc · Cited by 121 · see citing works

Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer

Meenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.012 · Cited by 110 · see citing works

Dimethylfumarate Attenuates Renal Fibrosis via NF-E2-Related Factor 2-Mediated Inhibition of Transforming Growth Factor-β/Smad Signaling

Oh, C. J., Kim, J.-Y., Choi, Y.-K., Kim, H., Jeong, J., Bae, K.-H., Park, K., & Lee, I.-K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045870 · Cited by 107 · see citing works

Differences in Airway Remodeling Between Asthma and Chronic Obstructive Pulmonary Disease

Aoshiba, K., & Nagai, A. (2004) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:27:1:035 · Cited by 105 · see citing works

Nanocarriers in therapy of infectious and inflammatory diseases

Ikoba, U., Peng, H., Li, H., Miller, C. L., Yu, C., & Wang, Q. (2015) · Nanoscale · doi:10.1039/c4nr07682f · Cited by 102 · see citing works

Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes

Buist, A. S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00404903 · Cited by 100 · see citing works

HIF and pulmonary vascular responses to hypoxia

Shimoda, L. A., & Laurie, S. S. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00643.2013 · Cited by 95 · see citing works

Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols

Park, C., Li, X., Vogt, F. G., Hayes, D., Zwischenberger, J. B., Park, E., & Mansour, H. M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.047 · Cited by 94 · see citing works

Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying

Stocke, N. A., Meenach, S. A., Arnold, S. M., Mansour, H. M., & Hilt, J. Z. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.050 · Cited by 91 · see citing works

Dry powder inhalers in COPD, lung inflammation and pulmonary infections

Muralidharan, P., Hayes, D., & Mansour, H. M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.977783 · Cited by 91 · see citing works

Dimethylfumarate inhibits NF-κB function at multiple levels to limit airway smooth muscle cell cytokine secretion

Seidel, P., Merfort, I., Hughes, J. M., Oliver, B. G. G., Tamm, M., & Roth, M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90624.2008 · Cited by 89 · see citing works

Dimethyl fumarate – only an anti‐psoriatic medication?

Meißner, M., Valesky, E. M., Kippenberger, S., & Kaufmann, R. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07996.x · Cited by 84 · see citing works

Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols

Mansour, H. M., Meenach, S. A., Vogt, McGarry, Anderson, �., & Hilt, J. Z. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30724 · Cited by 77 · see citing works

Endothelin-1 Induces a Glycolytic Switch in Pulmonary Arterial Endothelial Cells via the Mitochondrial Translocation of Endothelial Nitric Oxide Synthase

Sun, X., Kumar, S., Sharma, S., Aggarwal, S., Lü, Q., Groß, C., Rafikova, O., Lee, S. G., Dasarathi, S., Hou, Y., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0187oc · Cited by 75 · see citing works

Activation of Nrf2 by dimethyl fumarate improves vascular calcification

Ha, C., Park, S., Choi, Y., Jeong, J.-Y., Oh, C. J., Bae, K.-H., Lee, S. J., Kim, J., Park, K., Jun, D. Y., et al. (2014) · Vascular Pharmacology · doi:10.1016/j.vph.2014.06.007 · Cited by 71 · see citing works

High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

Meenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0182-z · Cited by 69 · see citing works

Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Spray-Dried Microparticulate/Nanoparticulate Mannitol Powders for Targeted Pulmonary Delivery as Dry Powder Inhalers

Li, X., Vogt, F. G., Hayes, D., & Mansour, H. M. (2014) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2013.1078 · Cited by 62 · see citing works

Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery

Mansour, H. M., Duan, Vogt, Li, & Hayes, D. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s48631 · Cited by 59 · see citing works

Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery

Li, X., Vogt, F. G., Hayes, D., & Mansour, H. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.10.016 · Cited by 56 · see citing works

Physicochemical Characterization and Water Vapor Sorption of Organic Solution Advanced Spray-Dried Inhalable Trehalose Microparticles and Nanoparticles for Targeted Dry Powder Pulmonary Inhalation Delivery

Li, X., & Mansour, H. M. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9704-0 · Cited by 50 · see citing works

Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation

Mansour, H. M., Wu, Hayes, D., Zwischenberger, & Kuhn, R. J. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s40166 · Cited by 50 · see citing works

Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children

Hall, S., Brogan, P. A., Haworth, S. G., & Klein, N. J. (2009) · Thorax · doi:10.1136/thx.2008.106435 · Cited by 50 · see citing works

PPAR-γ Regulates Carnitine Homeostasis and Mitochondrial Function in a Lamb Model of Increased Pulmonary Blood Flow

Sharma, S., Sun, X., Rafikov, R., Kumar, S., Hou, Y., Oishi, P. E., Datar, S. A., Raff, G. W., Fineman, J. R., & Black, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041555 · Cited by 48 · see citing works

Experimental Therapeutics of Nrf2 as a Target for Prevention of Bacterial Exacerbations in COPD

Biswal, S. S., Thimmulappa, R. K., & Harvey, C. J. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-009ms · Cited by 47 · see citing works

Disruption of Endothelial Cell Mitochondrial Bioenergetics in Lambs with Increased Pulmonary Blood Flow

Sun, X., Sharma, S., Fratz, S., Kumar, S., Rafikov, R., Aggarwal, S., Rafikova, O., Lü, Q., Burns, T., Dasarathi, S., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4806 · Cited by 43 · see citing works

Design, Characterization, and Aerosol Dispersion Performance Modeling of Advanced Co-Spray Dried Antibiotics with Mannitol as Respirable Microparticles/Nanoparticles for Targeted Pulmonary Delivery as Dry Powder Inhalers

Li, X., Vogt, F. G., Hayes, D., & Mansour, H. M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23955 · Cited by 41 · see citing works

Anti-Inflammatory Dimethylfumarate: A Potential New Therapy for Asthma?

Seidel, P., & Roth, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/875403 · Cited by 40 · see citing works

DMF inhibits PDGF-BB induced airway smooth muscle cell proliferation through induction of heme-oxygenase-1

Seidel, P., Goulet, S., Hostettler, K., Tamm, M., & Roth, M. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-145 · Cited by 39 · see citing works

Systemic Oxidative Stress and Endothelial Dysfunction is Associated With an Attenuated Acute Vascular Response to Inhaled Prostanoid in Pulmonary Artery Hypertension Patients

Gabrielli, L., Castro, P., Godoy, I. E., Mellado, R., Bourge, R. C., Alcaíno, H., Chiong, M., Greig, D. P., Verdejo, H., Navarro-Márquez, M., et al. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.08.008 · Cited by 35 · see citing works

Dimethyl Fumarate Protects Pancreatic Islet Cells and Non-Endocrine Tissue in L-Arginine-Induced Chronic Pancreatitis

Robles, L. Y., Vaziri, N. D., Li, S., Masuda, Y., Takasu, C., Takasu, M., Vo, K. M., Farzaneh, S. H., Stamos, M. J., & Ichii, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107111 · Cited by 34 · see citing works

Dimethyl Fumarate Ameliorates Acute Pancreatitis in Rodent

Robles, L. Y., Vaziri, N. D., Li, S., Takasu, C., Masuda, Y., Vo, K. M., Farzaneh, S. H., Stamos, M. J., & Ichii, H. (2014) · Pancreas · doi:10.1097/mpa.0000000000000275 · Cited by 26 · see citing works

Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells

Firth, A. L., Yuill, K. H., & Sv, S. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90243.2008 · Cited by 26 · see citing works

Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy

Lounsbury, N., Mateo, G. D., Jones, B., Papaiahgari, S. R., Thimmulappa, R. K., Teijaro, C. N., Gordon, J. C., Korzekwa, K. R., Ye, M., Allaway, G. P., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.056 · Cited by 21 · see citing works

Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow

Sharma, S., Kumar, S., Sud, N., Wiseman, D. A., Tian, J., Rehmani, I., Datar, S. A., Oishi, P. E., Fratz, S., Venema, R. C., et al. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.005 · Cited by 19 · see citing works

Pulmonary and Nasal Anti-Inflammatory and Anti-Allergy Inhalation Aerosol Delivery Systems

Wu, X., Adedoyin, O. O., & Mansour, H. M. (2011) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523011109030215 · Cited by 13 · see citing works

Early Determinants of Pulmonary Vascular Remodeling in Animal Models of Complex Congenital Heart Disease

Fratz, S., Fineman, J. R., Görlach, A., Sharma, S., Oishi, P. E., Schreiber, C., Kietzmann, T., Adatia, I., Hess, J., & Black, S. M. (2011) · Circulation · doi:10.1161/circulationaha.110.978528 · Cited by 11 · see citing works

Molecular structure and infrared spectra of dimethyl fumarateElectronic supplementary information (ESI) available: Definition of internal symmetry coordinates, calculated frequencies, IR intensities, Raman activities, potential energy distributions and optimized conformers I, II and III. See http://www.rsc.org/suppdata/cp/b2/b203246p/

Lopes, S., Lapiński, L., & Fausto, R. (2002) · Physical Chemistry Chemical Physics · doi:10.1039/b203246p · Cited by 8 · see citing works

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles

Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works

Oxidative stress-based therapeutics in COPD

Barnes, P. J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101544 · Cited by 501 · see citing works

Oxidative Stress in Chronic Obstructive Pulmonary Disease

Barnes, P. J. (2022) · Antioxidants · doi:10.3390/antiox11050965 · Cited by 300 · see citing works

Patented therapeutic drug delivery strategies for targeting pulmonary diseases

Thakur, A. K., Chellappan, D. K., Dua, K., Mehta, M., Satija, S., & Singh, I. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1741547 · Cited by 132 · see citing works

Reactive oxygen species-scavenging nanomaterials for the prevention and treatment of age-related diseases

Dai, Y., Guo, Y., Tang, W., Chen, D., Xue, L., Chen, Y., Guo, Y., Wei, S., Wu, M., Dai, J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02501-9 · Cited by 116 · see citing works

Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review

Xu, Y., Liu, H., & Song, L. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00703-5 · Cited by 104 · see citing works

Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases

Chellappan, D. K., Yee, L. W., Xuan, K. Y., Kunalan, K., Rou, L. C., Jean, L. S., Ying, L. Y., Wie, L. X., Chellian, J., Mehta, M., et al. (2020) · Drug Development Research · doi:10.1002/ddr.21648 · Cited by 82 · see citing works

Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease

Cazzola, M., Cavalli, F., Usmani, O. S., & Rogliani, P. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1739021 · Cited by 76 · see citing works

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases

Kole, E. B., Jadhav, K., Shirsath, N. R., Dudhe, P. B., Verma, R. K., Chatterjee, A., & Naik, J. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104261 · Cited by 73 · see citing works

New perspectives in nanotherapeutics for chronic respiratory diseases

da Silva, A. L., Cruz, F. F., Rocco, P. R. M., & Morales, M. M. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0319-x · Cited by 72 · see citing works

Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases

Passi, M., Shahid, S., Chockalingam, S., Sundar, I. K., & Packirisamy, G. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s242516 · Cited by 65 · see citing works

The role of lung macrophages in chronic obstructive pulmonary disease

Wu, J., Zhao, X., Xiao, C., Xiong, G., Ye, X., Li, L., Yan, F., Chen, H., Yang, W., & Du, X. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107035 · Cited by 47 · see citing works

Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects

Zheng, M., Zhu, W., Gao, F., Zhuo, Y., Mo, Z., Wu, G., & Feng, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02407-6 · Cited by 50 · see citing works

Targeting COPD with PLGA‐Based Nanoparticles: Current Status and Prospects

Saxena, J., Bisen, M., Misra, A., Kumar, V., Kaushik, S., Siddiqui, A. J., Mishra, N., Singh, A., & Jyoti, A. (2022) · BioMed Research International · doi:10.1155/2022/5058121 · Cited by 44 · see citing works

Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery

Gomez, A. I., Acosta, M. F., Muralidharan, P., Yuan, J. X. ‐., Black, S. M., Hayes, D., & Mansour, H. M. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2020.101975 · Cited by 44 · see citing works

Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management

Liu, D., Long, M., Gao, L., Chen, Y., Fang, L., Shi, Y., & Gu, N. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112258 · Cited by 42 · see citing works

Association of nanoparticles and Nrf2 with various oxidative stress-mediated diseases

Thiruvengadam, R., Venkidasamy, B., Samynathan, R., Rajakumar, G., Thiruvengadam, M., & Kim, J. H. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110535 · Cited by 40 · see citing works

Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches

Reid, A. T., Veerati, P. C., Gosens, R., Bartlett, N. W., Wark, P. A. B., Grainge, C., Stick, S. M., Kicic, A., Moheimani, F., Hansbro, P. M., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.009 · Cited by 30 · see citing works

Nanotechnology: Advancing the translational respiratory research

Dua, K., Shukla, S. D., Pinto, T. D. J. A., & Hansbro, P. M. (2017) · Interventional Medicine and Applied Science · doi:10.1556/1646.9.2017.1.02 · Cited by 31 · see citing works

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers

Acosta, M. F., Abrahamson, M. D., Encinas-Basurto, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00531-3 · Cited by 29 · see citing works

Nanoparticles in the treatment of chronic lung diseases

Alexescu, T., Țărmure, S., Negrean, V., Cosnarovici, M. M., Ruta, V. M., Popovici, I., Para, I., Perné, M.-G., Orasan, O. H., & Todea, D. A. (2019) · Journal of Mind and Medical Sciences · doi:10.22543/7674.62.p224231 · Cited by 28 · see citing works

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols

Muralidharan, P., Mallory, E. K., Malapit, M., Phan, H., Ledford, J. G., Hayes, D., & Mansour, H. M. (2020) · RSC Advances · doi:10.1039/d0ra07203f · Cited by 28 · see citing works

Targeting oxidant-dependent mechanisms for the treatment of respiratory diseases and their comorbidities

Thomson, N. C. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.11.013 · Cited by 28 · see citing works

Nanoparticle-Based Drug Delivery for Chronic Obstructive Pulmonary Disorder and Asthma

Wadhwa, R., Aggarwal, T., Thapliyal, N., Chellappan, D. K., Gupta, G., Gulati, M., Collet, T., Oliver, B. G. G., Williams, K. A., Hansbro, P. M., et al. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818823-1.00005-3 · Cited by 25 · see citing works

Nanotechnology-Based Therapeutics for Targeting Inflammatory Lung Diseases

Loo, C., & Lee, W. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0447 · Cited by 24 · see citing works

Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies

Alabsi, W., Al‐Obeidi, F., Polt, R. L., & Mansour, H. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010026 · Cited by 19 · see citing works

Banhasasim-Tang Treatment Reduces the Severity of Esophageal Mucosal Ulcer on Chronic Acid Reflux Esophagitis in Rats

Shin, M.-R., Seo, B.-I., Son, C., Roh, S., & An, H. (2017) · BioMed Research International · doi:10.1155/2017/7157212 · Cited by 17 · see citing works

Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy

Muralidharan, P., Acosta, M. F., Gomez, A. I., Grijalva, C. L., Tang, H., Yuan, J. X. ‐., & Mansour, H. M. (2021) · Antioxidants · doi:10.3390/antiox10030427 · Cited by 16 · see citing works

Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

Acosta, M. F., Muralidharan, P., Grijalva, C. L., Abrahamson, M. D., Hayes, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466621998245 · Cited by 17 · see citing works

Senotherapy for chronic lung disease

Barnes, P. J. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100069 · Cited by 17 · see citing works

Target Nuclear Factor Erythroid 2‐Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application

Qin, Y., Qiao, Y., Wang, D., Li, L., Li, M., Yan, G., & Tang, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7845503 · Cited by 14 · see citing works

Metallomics in pulmonary arterial hypertension patients

El‐Kersh, K., Hopkins, C. D., Wu, X., Rai, S. N., Cave, M. C., Smith, M. R., Go, Y., Jones, D. P., Cai, L., & Huang, J. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12202 · Cited by 13 · see citing works

The putative interplay between DJ-1/NRF2 and Dimethyl Fumarate: A potentially important pharmacological target

Vavougios, G. D., Zarogiannis, S. G., & Doskas, T. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.02.027 · Cited by 13 · see citing works

Delivery strategies to improve the pharmacological efficacy of NRF2 modulators: a review

Bayındır, Z. S., Sova, M., Yüksel, N., & Saso, L. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00571j · Cited by 12 · see citing works

Targeted Delivery of Surface-Modified Nanoparticles: Modulation of Inflammation for Acute Lung Injury

Nguyen, H. X. (2019) · Springer eBooks · doi:10.1007/978-3-030-06115-9_17 · Cited by 11 · see citing works

Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH

Acosta, M. F., Muralidhran, P., Abrahamson, M. D., Grijalva, C. L., Carver, M., Tang, H., Klinger, C. N., Fineman, J. R., Black, S. M., & Mansour, H. M. (2020) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.101998 · Cited by 10 · see citing works

Towards improved pharmacotherapy in pulmonary arterial hypertension. Can diet play a role?

Semen, K. O., & Bast, A. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.12.087 · Cited by 9 · see citing works

Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist

Muralidharan, P., Jones, B., Allaway, G. P., Biswal, S. S., & Mansour, H. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-76585-2 · Cited by 9 · see citing works

A quantitative proteomic approach to evaluate the efficacy of carnosine in a murine model of chronic obstructive pulmonary disease (COPD)

D’Amato, A., Altomare, A., Gilardoni, E., Baron, G., Carini, M., Melloni, E., Padoani, G., Vailati, S., Caponetti, G., & Aldini, G. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103374 · Cited by 8 · see citing works

Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery

Muralidharan, P., Hayes, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122188 · Cited by 7 · see citing works

Inflammatory lung diseases: a clinical and scientific review of the latest advances and challenges

Katamesh, A. A., Almansour, K., Hassoun, S. M., Sayed, O. M., Break, M. K. B., Zaki, R. M., Afzal, O., & Radwan, A. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00749-y · Cited by 6 · see citing works

Advanced Spray-Dried Inhalable Microparticles/Nanoparticles of an Innovative Mitophagy Activator for Targeted Lung Delivery: Design, Comprehensive Characterization, Human Lung Cell Culture, and In Vitro Aerosol Dispersion Performance

Sofi, H. S., Lora, A. J., Donow, H. M., Aggarwal, S., Fu, P., Wang, T., & Mansour, H. M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00436 · Cited by 6 · see citing works

Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling

Fang, Q., Bai, Y., Hu, S., Ding, J., Liu, L., Dai, M., Qiu, J., Wu, L., Rao, X., & Wang, Y. (2023) · Antioxidants · doi:10.3390/antiox12111978 · Cited by 5 · see citing works

Dextran-based Drug Delivery Approaches for Lung Diseases: A Review

Kumari, M., Sharma, S., Kanwar, N., Naman, S., & Baldi, A. (2024) · Current Drug Delivery · doi:10.2174/0115672018267737231116100812 · Cited by 5 · see citing works

Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR)

Beeraka, N. M., Zhou, R., Wang, X., R, H. V. P., Kumar, T. P., Liu, J., Greeshma, M. V., Mandal, S. P., Gurupadayya, B., & Fan, R. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s364693 · Cited by 5 · see citing works

Targeting Multiple Pathophysiological Axes in COPD: Nanomaterial Advances

Zhang, Q., Xu, S., Yang, C., Wang, X., Liu, T., Zhang, X., Qu, C., Wu, J. ‐., Yang, J., & Xing, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s542725 · Cited by 5 · see citing works

Advancement in translational respiratory research using nanotechnology

Pandey, P., Purohit, D., Chellappan, D. K., Gupta, G., Tambuwala, M. M., Aljabali, A. A. A., Satija, S., & Dureja, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820658-4.00010-8 · Cited by 4 · see citing works

Advances in Nanoparticulate Therapeutics for Acute Lung Injury: Addressing Unmet Clinical Needs through Targeted Therapy and Controlled Delivery of Drug

Sadhu, P., Kumari, M., Rajput, H. S., Patel, V. P., Rathod, F., Shah, N. V., & Seth, A. K. (2024) · Current Nanomedicine · doi:10.2174/0124681873285123240206094443 · Cited by 2 · see citing works

Inhalable Advanced Co-Spray Dried Microparticles/Nanoparticles of a Novel RhoA/Rho Kinase Inhibitor with Lung Surfactant Biomimetic Phospholipids for Targeted Lung Delivery

Ruiz, V. H., Encinas-Basurto, D., Alarcon, N. O., Eedara, B. B., Fineman, J. R., Black, S. M., & Mansour, H. M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00432 · Cited by 2 · see citing works

Modulation of Pulmonary Inflammation and the Redox Pathway In Vitro and In Vivo by Fumaric Ester

Cardoso, A. D. O. P., Figueiredo-Junior, A. T., Mineiro, P. C. D. O., Mota, E. C., Amorim, C. S., Valença, H. D. M., Gomes, A. C. C. D. A., Serra, S. S. D. S., Silva, P. L., Takiya, C. M., et al. (2025) · Antioxidants · doi:10.3390/antiox14091141 · Cited by 2 · see citing works

OXIDATIVE STRESS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Barnes, P. J. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch15 · Cited by 2 · see citing works

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032

Eedara, B. B., Manivannan, B., Alabsi, W., Sun, B., Curiel‐Lewandrowski, C. N., Zhang, T., Bode, A. M., & Mansour, H. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115515 · Cited by 1 · see citing works

Effects of E-Cigs on Physiological Pathways and Proposed Therapeutic Intervention with Bixin

Claymore, S. R., & Allen‐Gipson, D. (2024) · Biomedicines · doi:10.3390/biomedicines12122705 · Cited by 1 · see citing works

Comprehensive Physicochemical Characterization and in Vitro Human Cell Culture Studies of an Innovative Biocompatible and Biodegradable Silk-Derived Protein Hydrolysate, SDP-4

Sofi, H. S., Lora, A. J., Aggarwal, S., Infanger, D. W., Lawrence, B. D., & Mansour, H. M. (2025) · ACS Omega · doi:10.1021/acsomega.4c08514 · Cited by 1 · see citing works

Nanomedicine and Its Potential Therapeutic and Diagnostic Applications in Human Pathologies

Salvadori, M. R. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-82918-6_13 · Cited by 1 · see citing works

Utility of nanomedicine and nanocarriers for noninfectious disease treatment

Tuteja, J., Vyas, A., & Sand, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95325-2.00014-6 · Cited by 1 · see citing works

Nanomedicine Applied to Inflammatory and Infectious Pulmonary Diseases

Kaur, A., Sharma, R., Sundar, I. K., & Packirisamy, G. (2023) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-19-8342-9_11

Innovative Dual Combination Cospray-Dried Rock Inhibitor/ l -Carnitine Inhalable Dry Powder Aerosols

Acosta, M. F., Encinas-Basurto, D., Abrahamson, M. D., Eedara, B. B., Hayes, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2024) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.4c00063

Comprehensive physicochemical, biophysical, and in vitro characterization of lung surfactant SP-A peptidomimetics

Encinas-Basurto, D., Muralidharan, P., Islam, M. D. S., Vallorz, E. L., Black, S. M., Kraft, M., Ledford, J. G., & Mansour, H. M. (2025) · RSC Pharmaceutics · doi:10.1039/d4pm00265b

Advanced Spray-Dried Cyanidin Chloride Inhalable Dry Powders with High Aerosol Dispersion Performance and Mitochondrial Bioenergetics Modulation for Targeted Pulmonary Delivery

Shafi, H., Muralidharan, P., Encinas-Basurto, D., & Mansour, H. M. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00181

Theranostic innovation in infectious lung diseases: integrating biotechnology and nanotechnology for precision medicine

Jafari, A., Manzari‐Tavakoli, A., Tavakoli, M. M., Hashemian, S. M., Jamaati, H., Akhtari, M., Tabarsi, P., & Omrani, M. (2026) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2026.2714060

Precision nanomedicine for pulmonary diseases: from molecular targeting to clinical translation

Deng, Z., Gao, W., Do, J., Aragam, S., Dawd, O., Belthur, M., Shi, D., Kalin, T. V., & Kalinichenko, V. V. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02982-0

Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

Acosta, M. F., Muralidharan, P., Grijalva, C. L., Abrahamson, M. D., Hayes, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466621998245 · Cited by 17 · see citing works

Route of administration significantly affects particle deposition and cellular recruitment

Yisrael, K., Drover, R. W., Shapiro, M. L., Anguiano, M., Kachour, N., Li, Q., Tran, E., Cocker, D. R., & Lo, D. D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289373 · Cited by 8 · see citing works

Lung deposition predictions of airborne particles and the emergence of contemporary diseases Part-I

Hussain, M., Madl, P., Alam, K., & Khan, A. A. P. (2011) · Cited by 97 · see citing works

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers

Acosta, M. F., Abrahamson, M. D., Encinas-Basurto, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00531-3 · Cited by 29 · see citing works

Dry Lung as a Physical Model in Studies of Aerosol Deposition

Morozov, V. N., & Kanev, I. L. (2015) · Lung · doi:10.1007/s00408-015-9783-x · Cited by 6 · see citing works